China Shineway Pharmaceutical Group Limited
HKEx Stock Code: 02877 Chinese
Financial Reports
Annual Report  2020 2019
Annual Report
Monthly Newsflash
2020 Jul Newsflash 2020
Jul Newsflash
Financial Calendar
Ex-Dividend Day
4 June 2020
  China Shineway Pharmaceutical Group Limited is the largest Chinese medicine injection and soft capsule manufacturer in the PRC. Our shares are listed on the Main Board of Hong Kong Stock Exchange. Shineway is one of the Hang Seng Composite Index constituents and is named by Forbes Magazine as Asia's Best 200 Under a Billion.

Our products are primarily categorized into three major types: injection, soft capsule and granule, targeting three market segments with high growth potential, namely the middle and old aged, anti-viral and children, and are marketed under the "SHINEWAY" brand - a China Famous Trademark.
Latest News
Announcements and Notices - POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 29 MAY 2020   29 May 2020
Announcements and Notices - TURNOVER FOR THE FIRST QUARTER OF 2020   08 May 2020
Announcements and Notices - Notice of Annual General Meeting   24 Apr 2020
Product Highlight
Qingkailing Soft Capsules
Clearing away heat and toxins...
Related Links
Email Alerts
Industry Regulations
Shineway's China Website Related Website of Pharmaceutical Industry